Clinical Trial

Quadratus Lumborum Block After Cesarean Section: Analgesic Efficacy of Different Concentrations of Local Anesthetics

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 31, 2024 (before its estimated September 6, 2025 completion). Its status may not reflect the trial's current state.
Summary
QLB is an injection of a local anesthetics around the quadratus lumborum muscle. It uses a fascial compartment path to extend the distribution of local anesthetics into the posterior abdominal wall and paravertebral space. This central effect can be of vital importance when managing the visceral pain after caesarean section. Many studies have shown that the inclusion of quadratus lumborum block to a multimodal analgesic regimen would reduce pain scores, opioid consumption, and prolonging time to first rescue analgesic after cesarean delivery. However, the dose and concentration of the local anesthetic used among the studies are varied, and literature search identified no randomized controlled trial which looked at the concentration -response of local anesthetic to optimize the concentration resulting in the best pain relief. It is a perspective randomized controlled trial to compare the analgesic efficacy of 2 different concentrations of Bupivacaine to standardize postoperative analgesic protocol used for QLB after caesarean section.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-12-01; most recent amendment 2024-12-28.
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-12-28
Trial Details
NCT Number NCT05643846
Lead Sponsor Danat Al Emarat Hospital
Conditions Outcome Measures
Enrollment 196 participants
Start Date 2023-02-27
Primary Completion 2025-09-06 (estimated)
Study Completion 2025-12-06 (estimated)
Updated on ClinicalTrials.gov 2024-12-31